Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1359.40
-15.15 (-1.10%) Dr Reddys Laboratories informs about Press Release
Date: 23-03-2015Dr Reddys Laboratories has informed regarding a Press Release dated March 23, 2015 titled 'Dr. Reddys Laboratories enters into partnership with Hetero to accelerate access to treatment for Hepatitis C in India'.
The above information is a part of company’s filings submitted to BSE.